TrialsWest

11/11/2024

Click here to register your interest

02/10/2024

15/08/2023

📣 New Clinical Trial Announcement

TrialsWest is now recruiting participants to be involved in a clinical trial testing a potential new treatment for Chronic Cough.

If you’d like more information, please email [email protected].

04/08/2023

TrialsWest is seeking people with COPD for a clinical trial.

The purpose of this study is to investigate whether a treatment
called Tozorakimab could help manage COPD exacerbations (or flare-ups) in patients who are currently receiving treatment for COPD.

We are currently looking for people who have had at least one flare-up of their COPD symptoms in the last 12 months.

If you or anyone you know is interested in this study, please comment below or send an email to [email protected].

TrialsWest is an independent clinical trials organisation based in Perth WA. We partner with pharmaceutical and medical device companies to ensure the efficient delivery of clinical trials whilst maintaining our core focus of ensuring participant safety.

07/02/2023

TrialsWest is seeking people with chronic pain for a clinical trial.

The purpose of this study is to determine whether the study drug, called EMD-RX5, improves symptoms of psychological distress (including stress and anxiety) in people experiencing chronic pain.

EMD-RX5 is a medicinal cannabis product, with the active ingredient cannabidiol (also known as CBD).

If you or anyone you know is interested in this study, please comment below, send an email to [email protected] or you can register your interest here: https://trials.evrima.com/stress-anxiety-medical-study

09/08/2022

Established in 2012, TrialsWest is one of Australia’s most experienced and successful clinical research centres.

07/10/2021

Do you know someone over 60 years of age?
TrialsWest is helping investigate a global vaccine for a contagious virus that impacts everyone, and they could use your help.
Respiratory Syncytial Virus (RSV) presents like a common cold but can cause serious respiratory illness in older adults.
Currently, there is no approved RSV vaccine.
For more information, please call 08-9312 1931 or email [email protected]

01/10/2021

Do you or someone you know have Bronchiectasis?

Do you have NCFBE or related symptoms? You may be eligible for the ASPEN study, which evaluates a study drug for potential treatment of NCFBE.

16/04/2021

Researchers seek healthy adults